Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forget China And India, Clinical Trial Opportunities In Malaysia and South Korea

This article was originally published in PharmAsia News

Executive Summary

The opportunities for clinical trials in China and India are well known to the pharmaceutical industry at this point, but Edward Ian, senior director of clinical operations for PRA International-Asia Pacific, wants company leaders to take notice and advantage of the potential in other countries in Asia Pacific

You may also be interested in...



PharmAsia News' Top Industry Trends Of 2009

As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010

PharmAsia News' Top Industry Trends Of 2009

As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010

As Korea Steps Up Drive To Attract Global Clinical Trials, American CRO Opens Outpost In Seoul

SEOUL - PRA International, a clinical research organization headquartered in Raleigh, N.C., recently opened its first office in Seoul as part of an expansion across Asia

Related Content

UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel